Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers

BACKGROUND: Cyclin-dependent kinase inhibitor 2C (CDKN2C) was identified to participate in the occurrence and development of multiple cancers; however, its roles in small cell lung carcinoma (SCLC) remain unclear. METHODS: Differential expression analysis of CDKN2C between SCLC and non-SCLC were per...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guo-Sheng, Chen, Gang, Liu, Jun, Tang, Deng, Zheng, Jin-Hua, Luo, Jing, Jin, Mei-Hua, Lu, Hua-Song, Bao, Chong-Xi, Tian, Jia, Deng, Wu-Sheng, Fu, Jing-Wei, Feng, Yue, Zeng, Neng-Yong, Zhou, Hua-Fu, Kong, Jin-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233395/
https://www.ncbi.nlm.nih.gov/pubmed/35751045
http://dx.doi.org/10.1186/s12890-022-02036-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233395/
https://www.ncbi.nlm.nih.gov/pubmed/35751045
http://dx.doi.org/10.1186/s12890-022-02036-5

Ejemplares similares